Senior Surgeon, Massachusetts General Hospital
Professor of Surgery, Harvard Medical School
Chief Medical Officer, New England Donor Services
During his 40 year long career as a transplant surgeon at the Massachusetts General Hospital (MGH) and as Professor of Surgery Harvard Medical School, Francis L. Delmonico has uniquely contributed to changing the practice of organ donation and transplantation worldwide. His long standing career at the MGH was accomplished with the mentorship, support and direction of A. Benedict Cosimi and Paul S. Russell.
In 2005, Dr. Delmonico was elected president of the United Network of Organ Sharing/Organ Procurement Transplant Network (UNOS/OPTN) after 2 decades of UNOS committee leadership.
In 2008 as the Director of Medical Affairs (DMA) of TTS, Dr. Delmonico convened an international Summit of transplant professionals, legal scholars and ethicists in drafting the Declaration of Istanbul (DOI). This international policy document defined organ trafficking and transplant tourism, called for the equitable distribution of deceased donor organs and for the safety of transplant recipients and the wellbeing of living donors. The DOI is perhaps one of the most influential documents to standardize practices in the history of transplantation. Dr. Delmonico’s collaboration with the World Health Organization (WHO) was seminal in the development of WHO Guiding Principles of practice, subsequently adopted by the World Health Assembly.
He was elected president of The Transplantation Society (TTS) in 2012. The membership of TTS expanded greatly during his presidency to be inclusive of all professionals involved in the care of organ transplant recipients.
As Chief Medical Officer of New England Donor Services, formerly New England Organ Bank (NEOB) --for 25 years, his local and national leadership has been profound in establishing the medical suitability of organs derived from deceased donors. Dr. Delmonico initiated the first regional program of paired kidney donation in the United States in 2000 under the auspices of the NEOB. The NEOB was acknowledged for its contribution to the development of paired kidney exchange in the Nobel Prize awarded to Professor Alvin Roth in 2012.
Between 2008 and 2012, while serving on the National Kidney Foundation (NKF) Board of Trustees and as DMA of TTS, he convened and chaired conferences on the live organ donor for which he received the David M. Hume Lifetime Achievement Award. For his efforts to expand deceased donation worldwide, he was the recipient of an honorary doctorate at the Karolinska Institute.
In 2016, Dr. Delmonico was appointed by Pope Francis to the Pontifical Academy of Sciences following his nomination by Nobel Laureate Joseph Murray. Dr. Delmonico was responsible for convening the 2017 Pontifical Academy Summit on Organ Trafficking and Transplant Tourism.
In 2020, he convened an international group of experts to develop a Collaborative Statement to promote deceased organ donation after circulatory death; now widely distributed to the intensive care community.
Dr. Delmonico was a recipient of the 2020 Medawar Prize, acknowledging his lifetime contributions to the field. Dr. Delmonico is globally recognized for his commitment to promulgate the ethical practice of organ donation and transplantation for a common humanity. A visiting professorship has been established in Dr. Delmonico’s name at the Massachusetts General Hospital.
Dr. Shemie’s area of interest is organ replacement during critical illness and the continuum between life, death and oxygen delivery. He is a pediatric critical care physician, ECMO specialist and trauma team leader at the Montreal Children’s Hospital, McGill University Health Centre. He is a Professor of Pediatrics at the Montreal Children’s Hospital, McGill University and honourary staff in the Department of Critical Care Medicine, Hospital for Sick Children, University of Toronto. He is medical advisor, deceased organ donation, with Canadian Blood Services. His academic focus is advancing the science and practice of deceased organ donation. His research interests include the clinical and policy impact of organ failure support technologies, the development and implementation of national ICU-based leading practices in organ donation and research at the intersection of end-of-life care, death determination and deceased donation.
President & CEO, Gift of Life Donor Program
Howard Nathan is the longest-serving Chief Executive of any organ procurement organization in the United States, recently celebrating his 43rd anniversary with Gift of Life Donor Program in July 2021. Since 1974, the program has coordinated more than 54,000 organs for transplantation and approximately 2.0 million tissue transplants.
Gift of Life is one of the oldest of the 57 organ procurement organizations in the United States and under Mr. Nathan’s leadership has grown to be the largest organ donation program in the country, with a network of 15 transplant centers with 40 organ-specific programs and 128 donor hospitals.
In 2020, for the 13th consecutive year, Gift of Life Donor Program is the nation’s leading OPO, coordinating 619 organ donors, resulting in 1,621 organ transplants, the most life-saving organs for transplant among all 58 U.S. OPOs.
Considered one of the nation’s leading authorities on organ and tissue donation, Mr. Nathan is a regular presenter at national and international organ and tissue procurement, transplantation, and medical/healthcare conferences. He and has published more than 400 scientific papers and abstracts during his career and has travelled to over 30 countries to promote best practices in organ donation and transplantation.
He has served on numerous leadership boards including: United Network for Organ Sharing (UNOS), Association of Organ Procurement Organization (AOPO), North American Transplant Coordinators Organization (NATCO), International Society for Organ Donation and Procurement (ISODP), Donate Life America (DLA), LifeLogics, Inc., MTF Biologics (MTF) Board of Trustees, National Disease Research Interchange (NDRI), National Kidney Foundation (NKF), Organ Donation & Transplantation Alliance (The Alliance), and the Governor Robert P. Casey Memorial Trust Fund Organ Donation Advisory Committee (ODAC), Commonwealth of Pennsylvania, among others.
Mr. Nathan has appeared on hundreds of local, national and international television news and talk shows and has received numerous outstanding achievement awards, most recently Doctor of Humane Letters from Juniata College (2021), Lions Eye Bank of Delaware Valley “Knight of the Blind” Award (2017), Juniata College “Alumni Achievement Award” (2017), Donate Life America "Nicholas Green Lifetime Achievement Award” (2017), Transplant Recipients International Organization, Inc. (TRIO) Lifetime Achievement Award (2018), the Association of Organ Procurement Organizations (AOPO) President’s Award (2018), and Main Line Today “Healthcare Heroes” Award (2019).
National Medical Director, Australian Organ and Tissue Authority
Associate Professor Helen Opdam is the National Medical Director of the Australian Organ and Tissue Authority. She is a Senior Intensive Care Specialist at the Austin Hospital in Melbourne and Director of Warringal Private Hospital Intensive Care Unit.
Helen has been involved in organ donation since 1998, initially in developing an audit to determine the potential for organ donation. She was the inaugural Victorian State Medical Director for Organ and Tissue Donation at the time that the National Reform to boost donation in Australia began in 2009. She is a Council member of the International Society for Organ Donation and Procurement, and participates on key Australian committees including the Australian and New Zealand Intensive Care Society (ANZICS) Death and Organ Donation Committee and the National Health and Medical Research Council Expert Advisory Group for the development of ethical guidelines for organ transplantation from deceased donors.
She is a regular invited speaker at national and international conferences.
David Hartell is the Associate Director for System Development at Canadian Blood Services with the Organ and Tissue Donation and Transplantation Team. David helps to guide the development, implementation and evaluation of national clinical guidelines and leading practices, professional education and national data. He is the previous and founding Executive Director of the Canadian Donation and Transplantation Research Program and has been involved in the organ donation and transplantation community for the past 10 years.
Professor, Department of Surgery, Konkuk University Hospital
Ik Jin Yun, MD, PhD. is a Professor of Surgery at Konkuk University College of Medicine, the former Director of Transplant Center and department of Surgery. He has been a transplantation surgeon since 1996 and major in kidney and liver transplantation surgery. He is also the councilor of ISODP and Vital link Korea which is the NGO for the development and promotion for the organ donation. He is also the editor-in-chief of Korean Journal of Transplantation and executive member of directors of the Korean Society for transplantation. He is also a member of The Transplantation Society (TTS) and AST and ESOT. His academic interests are on the xenotransplantation and since 2011, he has received national funds for xeno-organ transplantation and going on experiments for the pig to NHP organ transplantation. He has been elected to the president of Korean Xenotransplantation Association (KXA) at this year.
Critical Care Subspecialist and Transplant Surgeon
David Thomson, MBChB, FCS(SA), MMed(Surg), Cert Crit Care is a consultant surgeon in the Transplant Unit and a subspecialist in Critical Care Department at Groote Schuur Hospital and the University of Cape Town. He completed his undergraduate training in 2002 at the University of Kwa-Zulu Natal and went on to specialise in surgery at the University of Cape Town completing his FCS(SA) in 2011 and MMed(Surgery) in 2012. Awarded the Garron Caine Travelling Fellowship he attended the Harvard Centre for Surgery and Public Health, Massachusetts General Hospital and Brigham and Women’s Hospital in Boston in 2014. He completed his sub-specialist qualification in Critical Care in 2015 and currently works in the ICU, directing the ECMO program at Groote Schuur Hospital and is still active in kidney and liver transplantation. David has an interest in medical education and promoting organ donation and transplantation and created the ongoing massive open online course Organ Donation: From Death to Life hosted on Coursera.org and runs ECMO training workshops nationally.
Lucinda Barry is the Chief Executive Officer of the Australian Organ and Tissue Donation and Transplantation Authority. Lucinda has a wealth of experience and knowledge in health care. In her exemplary career, she has held leadership roles within government, the public service and in health care management and delivery. Lucinda commenced her career as a Registered Nurse, specialising in Emergency and Major Trauma before becoming a Director of Nursing. Her career then moved into public policy, where she reached the highest level being appointed as the Prime Minister’s Senior Adviser on health and social policy.
Lucinda leads the national program to increase organ and tissue donation for transplantation in Australia. She chairs numerous committees, is a member of the National Organ Donation Retrieval and Transplantation Committee, the Jurisdictional Eye and Tissue Steering Committee, the COVID-19 Australian Transplantation and Donation Rapid Response Taskforce and the National Indigenous Kidney Transplantation Taskforce. Lucinda is the Oceania coordinator on the International Advisory Panel for the Commonwealth Tribute to Life and is a member of the COVID-19 International sharing forum. She is an invited speaker at both the national and international level.
Dr. Dale Gardiner is the Associate Medical Director – Deceased Organ Donation, at NHS Blood and Transplant and a Consultant in Adult Intensive Care Medicine at Nottingham University Hospitals NHS Trust.
His professional interests are medical ethics, the diagnosis of death and deceased organ donation. Dr Gardiner is chair of Nottingham’s Ethics of Clinical Practice Committee and co-chair of the deceased donation working group for ELPAT. He served for four years as a member of the UK Donation Ethics Committee until its closure in 2016.
Originally, he came from Australia but migrated to the UK in 2002
Managing Trustee, MOHAN Foundation
Currently he is President Elect of the Indian Society of Organ Transplantation and past President of the Nephrology, Urology & Transplantation Society of SAARC countries. He is the editor of the Editor the Indian Transplant Newsletter and advisory board member of the Indian Jr of Transplantation. A practicing urologist and a renal transplant surgeon at Madras Medical Mission Hospital in Chennai, he has also been active in the field of digital health and is the President of the Telemedicine Society of India, Tamil Nadu Chapter and course director for a foundation course for telemedicine for doctors in India. He has edited 6 books on Urology and Transplant Law. He has 14 book chapters, 130 articles in peer reviewed Journals to his credit with over 1,000 citations. He has been actively involved in promotion of deceased donations in India through the NGO called MOHAN. The NGO has won many awards for their pioneering efforts including the British Medical Association South Asia Award in 2015 for establishing ‘Cadaver program in India’ He is the recipient of the best teacher award from his medical university.
Director of Organ and Tissue Donation and Transplantation, NHS Blood and Transplant
Anthony Clarkson is a Registered Nurse and Director of Organ and Tissue Donation and Transplantation. Anthony started his career in tissue donation and prior to being appointed as the Director he spent a decade specialising in organ donation. During this time Anthony led the development of the UK wide organ donation service increasing donation rates by almost 100%. This work was recognised when Anthony was awarded the Clinical Leader of the Year in 2018. In February 2019 Anthony was appointed Director of Organ Donation and Transplantation and as led the creation of an integrated organ and tissue donation service. He has overseen the development of the 3rd UK Strategy for organ donation and transplantation which was published in June 2021. Anthony has been a ISODP Council member since 2019.
Executive Director, Donation and Transplantation Institute- DTI Foundation
Master in Donation & Transplantation of Organs, Tissues and Cells from Barcelona University. Dr. Gomez has 22 years of experience leading change processes in healthcare systems around the world. Executive Director of the Donation and Transplantation Institute (DTI Foundation) in Barcelona and medical coordinator of the International Registry for Organ Donation and Transplantation (IRODaT), councilor of the International Society for Organ Donation and Procurement (ISODP), member of both, The Transplantation Society (TTS) and the European Donation and Transplant Coordination Organization (EDTCO). Professor in the International Master in Donation & Transplantation of Organs, Tissues and Cells of the University of Barcelona.
She is the former CEO of Outcomes Australia and former member of the NSW Implementation Advisory Group for Increasing Organ Donation in New South Wales, Australia. During her role as the Acting Director of the Organ Donation for Transplantation Unit and her membership at the steering committee in Organ Donation in the Royal Prince Alfred Hospital in Sydney, she led the implementation of the leading practice in organ donation within the hospital.
Dr. Gómez was an observer member of the Council of Europe for Organ Donation during 2012 and 2013, DTI’s Medical Director from 2008 to 2013 and former National Transplant Director in Colombia 2005-2007.
Pediatric Intensivist, IWK Health and Dalhousie University
Kristina Krmpotic, MD, MSc, FRCPC is a Pediatric Intensivist and Assistant Professor in the Department of Critical Care at Dalhousie University. She is a donation physician for Legacy of Life, Nova Scotia, co-lead for activity 1 of the LEADDR program of research, and donation lead for the Academic Training Program of the Canadian Donation and Transplantation Research Program.